Back to today’s briefing

Story perspectives

India's Pharma Industry Set for 7.8% Revenue Surge

5/19/2025

37 6

Summary

Story summary

India's pharmaceutical industry is on a remarkable upward trajectory, anticipating a 7.8% revenue surge by April 2025. As the third-largest globally in volume, it achieved an impressive turnover of INR4.17 lakh crore in 2023-24. Government initiatives, such as PMBJP and PLI schemes, are not only making medicines more accessible but also driving vaccine production, drawing in INR12,822 crore in foreign investment.

1 of 1

Story summary

India's pharmaceutical industry is on a remarkable upward trajectory, anticipating a 7.8% revenue surge by April 2025. As the third-largest globally in volume, it achieved an impressive turnover of INR4.17 lakh crore in 2023-24. Government initiatives, such as PMBJP and PLI schemes, are not only making medicines more accessible but also driving vaccine production, drawing in INR12,822 crore in foreign investment.